Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2): a randomised, double-blind, placebo-controlled, phase 3 trial

The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection

Martín Rudwaleit, Désirée van der Heijde, R. B. M. Landewé et al. · Annals of the Rheumatic Diseases · 2009 · 3.6K citations · Full text

Medicine, Radiology, Musculoskeletal Medicine +11

Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis

Steven R. Ytterberg, Deepak L. Bhatt, Ted R. Mikuls et al. · New England Journal of Medicine · 2022 · 1.7K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis

Joachim Sieper, Martín Rudwaleit, Xenofon Baraliakos et al. · Annals of the Rheumatic Diseases · 2009 · 1.6K citations

Medicine, Clinical Sciences, Radiology +14

Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores

Pedro Machado, Robert Landewé, E. Lie et al. · Annals of the Rheumatic Diseases · 2010 · 797 citations

Medicine, Clinical Sciences, Pharmacotherapy +10

2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis

Michael M. Ward, Atul Deodhar, Lianne S. Gensler et al. · Arthritis & Rheumatology · 2019 · 631 citations

Medicine, Internal Medicine, Pharmacotherapy +16